Kristian Reich
Chief Scientific Officer · MoonLake Immunotherapeutics
- 2025
- Jul 29, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kristian Reich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- da Silva Jorge Santos - $8.73M in MLTX purchases and sales in the last 12 months
- Matthias Bodenstedt - $3.20M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristian Reich?
Kristian Reich is a corporate insider, tracked as Chief Scientific Officer of MoonLake Immunotherapeutics (MLTX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kristian Reich submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kristian Reich been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($8.14M) across all tracked filings.
